182 related articles for article (PubMed ID: 17976580)
21. Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia.
Scoto GM; Aricò G; Ronsisvalle S; Parenti C
Peptides; 2007 Jul; 28(7):1441-6. PubMed ID: 17628212
[TBL] [Abstract][Full Text] [Related]
22. The gastric effects of UFP-112, a new nociceptin/orphanin receptor agonist, in physiological and pathological conditions.
Broccardo M; Guerrini R; Morini G; Polidori C; Agostini S; Petrella C; Improta G
Peptides; 2007 Oct; 28(10):1974-81. PubMed ID: 17765363
[TBL] [Abstract][Full Text] [Related]
23. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
[TBL] [Abstract][Full Text] [Related]
24. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
Chiou LC; Liao YY; Fan PC; Kuo PH; Wang CH; Riemer C; Prinssen EP
Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536
[TBL] [Abstract][Full Text] [Related]
25. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
[TBL] [Abstract][Full Text] [Related]
26. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
Guerrini R; Carra' G; Calo' G; Trapella C; Marzola E; Rizzi D; Regoli D; Salvadori S
J Pept Res; 2004 Jun; 63(6):477-84. PubMed ID: 15175020
[TBL] [Abstract][Full Text] [Related]
27. Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux.
D'Agostino B; Marrocco G; De Nardo M; Calò G; Guerrini R; Gallelli L; Advenier C; Rossi F
Br J Pharmacol; 2005 Mar; 144(6):813-20. PubMed ID: 15685213
[TBL] [Abstract][Full Text] [Related]
28. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.
Calo G; Guerrini R; Rizzi A; Salvadori S; Burmeister M; Kapusta DR; Lambert DG; Regoli D
CNS Drug Rev; 2005; 11(2):97-112. PubMed ID: 16007234
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex.
Mela F; Marti M; Ulazzi L; Vaccari E; Zucchini S; Trapella C; Salvadori S; Beani L; Bianchi C; Morari M
Eur J Neurosci; 2004 Mar; 19(5):1317-24. PubMed ID: 15016089
[TBL] [Abstract][Full Text] [Related]
30. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study.
Linari G; Agostini S; Broccardo M; Petrella C; Improta G
Pharmacol Res; 2006 Nov; 54(5):356-60. PubMed ID: 16979347
[TBL] [Abstract][Full Text] [Related]
31. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
Chiou LC
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
[TBL] [Abstract][Full Text] [Related]
32. UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor.
Calo' G; Rizzi A; Cifani C; Micioni Di Bonaventura MV; Regoli D; Massi M; Salvadori S; Lambert DG; Guerrini R
CNS Neurosci Ther; 2011 Jun; 17(3):178-98. PubMed ID: 20497197
[TBL] [Abstract][Full Text] [Related]
33. Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation.
Trombella S; Vergura R; Falzarano S; Guerrini R; Calo G; Spisani S
Peptides; 2005 Aug; 26(8):1497-502. PubMed ID: 15922491
[TBL] [Abstract][Full Text] [Related]
34. Modulation of silent and constitutively active nociceptin/orphanin FQ receptors by potent receptor antagonists and Na+ ions in rat sympathetic neurons.
Mahmoud S; Margas W; Trapella C; Caló G; Ruiz-Velasco V
Mol Pharmacol; 2010 May; 77(5):804-17. PubMed ID: 20159949
[TBL] [Abstract][Full Text] [Related]
35. Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice.
Gavioli EC; Vaughan CW; Marzola G; Guerrini R; Mitchell VA; Zucchini S; De Lima TC; Rae GA; Salvadori S; Regoli D; Calo' G
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):547-53. PubMed ID: 15197534
[TBL] [Abstract][Full Text] [Related]
36. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
Zhang Y; Simpson-Durand CD; Standifer KM
Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex.
Marti M; Stocchi S; Paganini F; Mela F; De Risi C; Calo' G; Guerrini R; Barnes TA; Lambert DG; Beani L; Bianchi C; Morari M
Br J Pharmacol; 2003 Jan; 138(1):91-8. PubMed ID: 12522077
[TBL] [Abstract][Full Text] [Related]
38. GIRK channel-mediated inhibition of melanin-concentrating hormone neurons by nociceptin/orphanin FQ.
Parsons MP; Hirasawa M
J Neurophysiol; 2011 Mar; 105(3):1179-84. PubMed ID: 21191090
[TBL] [Abstract][Full Text] [Related]
39. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
Marti M; Mela F; Veronesi C; Guerrini R; Salvadori S; Federici M; Mercuri NB; Rizzi A; Franchi G; Beani L; Bianchi C; Morari M
J Neurosci; 2004 Jul; 24(30):6659-66. PubMed ID: 15282268
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
